Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy.

Abstract

PSA values are of major prognostic significance in assessing the 4-year results of radical radiation therapy for localized prostate cancer. The rate of decline of PSA values is the strongest predictor of outcome and might help to identify a subset of patients with poorer prognosis who may benefit from early hormonal therapy.